25/06/2019 16:09:17

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Allergan plc to AbbVie Inc. is Fair to Shareholders

NEW YORK, June 25, 2019 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased 

Allergan plc (“Allergan” or the “Company”) (NYSE: AGN) stock prior to June 25, 2019.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale ofAllergan to AbbVie Inc. (“AbbVie”) (NYSE: ABBV). Under the terms of the deal, Allergan Shareholders will receive 0.8660 AbbVie Shares and $120.30 in cash for each Allergan Share that they hold. To learn more about the action and your rights, go to:

https://www.zlk.com/mna/allergan-plc

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

The Allergan merger investigation concerns whether the Board of Allergan breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether AbbVie is underpaying for Allergan shares, thus unlawfully harming Allergan shareholders.

Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

250x148_zlk.jpg

Related content
13 Jul - 
Investor Rights Alert: Halper Sadeh LLP Continues Inves..
03 Jul - 
Bragar Eagel & Squire, P.C. Reminds Investors that it i..
26 Jun - 
Bragar Eagel & Squire, P.C. is Investigating the Board ..
Related debate
28 Jun - 
Jeg købte den desværre til kurs 77 dagen før den fik en..
28 Jun - 
Jeg kar kikket lidt mere på Abbvie og deres køb af Alle..
27 Jun - 
Også helt enig - super spændende aktie med potentiale! ..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zuora, Inc. - ZUO
2
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pivotal Software, Eros International, Teva Pharmaceutical Industries, and Helius Medical Technologies and Encourages Investors to Contact the Firm
3
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Anheuser-Busch, FedEx Corporation, EQT Corporation, and Sunlands Technology Group and Encourages Investors to Contact the Firm
4
Huazhu Group Limited Announces Its Preliminary Results for Hotel Operation in the Second Quarter of 2019
5
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of A. O. Smith Corporation - AOS

Related stock quotes

AbbVie Inc 69.16 -1.6% Stock price decreasing
Allergan PLC Ordinary Sh.. 164.26 -1.1% Stock price decreasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
17 July 2019 08:12:49
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190703.1 - EUROWEB3 - 2019-07-17 09:12:49 - 2019-07-17 08:12:49 - 1000 - Website: OKAY